Rectal Cancer clinical trials at UCSF
5 in progress, 2 open to eligible people
Rectal cancer occurs when cancerous cells develop in the rectum. UCSF is researching how different diets and fitness programs affect cancer survivors' well-being. They're also examining how chemotherapy and radiation treatment work for anal cancer in HIV-positive patients.
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
open to eligible people ages 18 years and up
This clinical trial studies the effect of four different intervention components "tools" on body weight, nutrition, and physical activity in cancer survivors. Studies indicate that people with a history of cancer whose nutrition and physical…
San Francisco, California
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
open to eligible people ages 18 years and up
This phase II trial studies the side effects of chemotherapy and intensity modulated radiation therapy in treating patients with low-risk HIV-associated anal cancer, and nivolumab after standard of care chemotherapy and radiation therapy in treating …
San Francisco, California and other locations
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Sorry, in progress, not accepting new patients
The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/capecitabine and radiation therapy) prior to surgery. Although radiation therapy to the pelvis has …
San Francisco, California and other locations
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Sorry, in progress, not accepting new patients
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as fluorouracil, oxaliplatin, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or by…
San Francisco, California and other locations
Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Sorry, in progress, not accepting new patients
The study is designed to test the hypothesis that patients with Locally advanced rectal cancer ( LARC) treated with Total neoadjuvant therapy (TNT) and Total mesorectal excision (TME) or Non-operative management (NOM) will have an improved 3-year…
San Francisco, California and other locations
Our lead scientists for Rectal Cancer research studies include Chia-Ching (Jackie) Wang Erin Van Blarigan, ScD.
Last updated: